These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31384882)

  • 1. Cancer screening in Australia: successes, challenges and future directions.
    Aranda S; Currow DC
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384882
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing rates of cancer screening.
    Kisiel JB; Parks P
    Am J Manag Care; 2018 Dec; 24(13 Spec No.):SP586-SP588. PubMed ID: 30556681
    [No Abstract]   [Full Text] [Related]  

  • 3. [The diffusion of screening programmes in Italy, year 2010].
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History, development and future of cancer screening in Australia.
    Olver IN; Roder D
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers.
    Weber MF; Marshall HM; Rankin N; Duffy S; Fong KM; Dunlop K; Humphries L; Smit AK; Cust AE; Taylor N; Mitchell G; Kang YJ; Tucker K; Jenkins M; Macrae F; Lockart I; Danta M; Armstrong BK; Howe M
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Centre for Screening Monitoring. Foreword.
    Oleari F
    Epidemiol Prev; 2009; 33(3 Suppl 2):3-6. PubMed ID: 19957412
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in Breast, Colorectal, and Cervical Cancer Incidence Following the Affordable Care Act: Implications for Cancer Screening.
    Sun M; Cole AP; Lipsitz SL; Trinh QD
    JAMA Oncol; 2018 Jan; 4(1):128-129. PubMed ID: 29098266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013.
    Suh M; Choi KS; Park B; Lee YY; Jun JK; Lee DH; Kim Y
    Cancer Res Treat; 2016 Jan; 48(1):1-10. PubMed ID: 25943324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey.
    Park B; Choi KS; Lee YY; Jun JK; Seo HG
    Asian Pac J Cancer Prev; 2012; 13(4):1187-91. PubMed ID: 22799303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain.
    Lo SH; Waller J; Wardle J; von Wagner C
    J Med Screen; 2013 Jun; 20(2):73-9. PubMed ID: 23761420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACS releases updated guidelines on cancer screening.
    Lambert M
    Am Fam Physician; 2012 Sep; 86(6):571, 576-7. PubMed ID: 23062051
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.
    Corley DA; Haas JS; Kobrin S
    JAMA; 2016 May; 315(19):2067-8. PubMed ID: 27089237
    [No Abstract]   [Full Text] [Related]  

  • 15. Implementation and organization of cancer screening in France.
    Hamers FF; Assogba FAG; Rogel A
    Int J Cancer; 2018 Dec; 143(12):3281. PubMed ID: 29943827
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cancer screening programmes in Italy: unification element or factor for further division?].
    Zappa M; Federici A; Salmaso S
    Epidemiol Prev; 2011; 35(5-6 Suppl 2):100-2. PubMed ID: 22166878
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary care colorectal cancer screening correlates with breast cancer screening: implications for colorectal cancer screening improvement interventions.
    Weiss JM; Pandhi N; Kraft S; Potvien A; Carayon P; Smith MA
    Clin Transl Gastroenterol; 2018 Apr; 9(4):148. PubMed ID: 29691364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key indicators of organized cancer screening programs: Results from a Delphi study.
    Csanádi M; de Kok IM; Heijnsdijk EA; Anttila A; Heinävaara S; Pitter JG; Széles G; Ivanuš U; Priaulx J; Veerus P; Senore C; Koning HJ; Vokó Z
    J Med Screen; 2019 Sep; 26(3):120-126. PubMed ID: 30621498
    [No Abstract]   [Full Text] [Related]  

  • 19. Introduction. The diffusion of screening programmes in Italy: 2007.
    Zappa M; Naldoni C; Paci E; Segnan N; Vettorazzi C; Federici A
    Epidemiol Prev; 2009; 33(3 Suppl 2):7-10. PubMed ID: 19776483
    [No Abstract]   [Full Text] [Related]  

  • 20. Capsule Commentary on Tosteson et al., Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Kolade VO; Meseeha MG
    J Gen Intern Med; 2016 Apr; 31(4):411. PubMed ID: 26857730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.